| 2018-10-20 | A novel TRAP1 inhibitor, containing flexible triphenylphosphonium, interacted with an allosteric site involving E403 residue and triggered protein conformational changes | Yoon, Nam Gu; Kang, Byoung Heon | CONFERENCE | 19 |
| 2002 | Caspase-3 has enhanced proteolytic properties at acidic pH | Kang, Byoung Heon | CONFERENCE | 7 |
| 2000-10 | Characterization of active-site residues of the NIa protease from tobacco vein mottling virus | Hwang, DC; Kim, DH; Lee, JS; Kang, Byoung Heon; Han, J; Kim, W; Song, BD; Choi, KY | ARTICLE | 638 |
| 1996-07 | Characterization of Nla protease from turnip mosaic potyvirus exhibiting a low-temperature optimum catalytic activity | Kim, DH; Hwang, D; Kang, Byoung Heon; Lew, J; Choi, KY | ARTICLE | 545 |
| 2017-05-18 | Chemical approaches to development of mitochondrial-targeted Hsp90 inhibitor as anti-cancer drug: Mechanism and conformational change of mitochondrial Hsp90 | Hu, Sung; Yoon, Nam gu; Jung, Hyun suck; Han, In cheol; Kang, Byoung Heon | CONFERENCE | 10 |
| 2017-04-03 | Chemical approaches to development of mitochondrial-targeted Hsp90 inhibitor as anti-cancer therapeutics: Mechanism and conformational change of mitochondrial Hsp90 | Hu, Sung; Yoon, Nam Gu; Kang, Byoung Heon | CONFERENCE | 12 |
| 2013 | Combination effect on Gamitrinib-TPP on tamoxifen-resistant breast cancer cell line | Kang, Byoung Heon; None; None | CONFERENCE | 7 |
| 2014-06 | Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim | Park, Hye-Kyung; Lee, Ji-Eun; Lim, Jaehwa; Jo, Da-Eun; Park, Soo-Ah; Suh, Pann-Ghill; Kang, Byoung Heon | ARTICLE | 761 |
| 2009-03 | Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90 | Kang, Byoung Heon; Plescia, Janet; Song, Ho Young; Meli, Massimiliano; Colombo, Giorgio; Beebe, Kristin; Scroggins, Bradley; Neckers, Len; Altieri, Dario C. | ARTICLE | 604 |
| 2009-10 | Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones | Kang, Byoung Heon; Altieri, D. C. | ARTICLE | 598 |
| 2014-12 | Crystallization and preliminary X-ray diffraction analysis of Trap1 complexed with Hsp90 inhibitors | Kang, Byoung Heon; Jeong, Hanbin; Lee, Changwook | ARTICLE | 906 |
| 2017-05-31 | Cyclophilin D defect impairs ROS regulation and increases invasion of cancer cells | Park,Hye-Kyung; Kang, Byoung Heon | CONFERENCE | 10 |
| 2015-02 | Cytotoxic effects of Tenebrio molitor larval extracts against hepatocellular carcinoma | Lee, ji-Eun; Lee, An-Jung; Jo, Da-Eun; Cho, Ju Hyeong; Youn, Kumju; Yun, Eun-Young; Hwang, Jae-Sam; Jun, Mira; Kang, Byoung Heon | ARTICLE | 1192 |
| 2015-04 | Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1 | Lee, Changwook; Park, Hye-Kyung; Jeong, Hanbin; Lim, Jaehwa; Lee, An-Jung; Cheon, Keun Young; Kim, Chul-Su; Thomas, Ajesh P.; Bae, Boram; Kim, Nam Doo; Kim, Seong Heon; Suh, Pann-Ghill; Ryu, Ja-Hyoung; Kang, Byoung Heon | ARTICLE | 957 |
| 2016-12-09 | Development of Hsp90 family protein inhibitors | Park, Hye-Kyung; Ko, Eunhwa; Lee, Geumwoo; Lee, Ji-Eun; Lee, Sang Kwang; Jeong, Hanbin; Lee, An-Jung; Im, Jin Young; Kim, Seong Heon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon | CONFERENCE | 14 |
| 2015-04-18 | Development of Hsp90 paralog specific inhibitors with mitochondrial drug delivery system | Kang, Byoung Heon | CONFERENCE | 952 |
| 2015-11-12 | Development of Hsp90 paralog specific inhibitors with mitochondrial drug delivery system | Kang, Byoung Heon | CONFERENCE | 8 |
| 2016-06-23 | Development of in vivo pan-Hsp90 inhibitors as cancer therapeutics | Kang, Byoung Heon | CONFERENCE | 7 |
| 2016-11-25 | Development of mitochondria-targeted Hsp90 inhibitor as a anti-cancer drug | Park, Hye-Jyung; Ko, Eunhwa; Lee, Gemwoo; Lee, Ji-Eun; Lee, Sang Kwang; Jeong, Hanbin; Lee, An-Jung; Im, Jing Young; Hu, Sung; Kim, Seong Heon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon | CONFERENCE | 19 |
| 2011 | Development of mitochondria-targeted Hsp90 inhibitors as effective cancer therapeutics | Kang, Byoung Heon | CONFERENCE | 6 |
